2014 Discharge: European Medicines Agency (EMA)

This procedure concerns the European Medicines Agency's (EMA) financial management for the 2014 budget year. It involves Parliament's decision on whether the EMA correctly implemented its budget and managed its finances, ensuring accountability and transparency in public spending.

The decision affects the EMA's operations and its stakeholders, including the pharmaceutical industry and public health bodies. It confirms the proper use of EU funds and contributes to the overall financial oversight of EU agencies.